ValueWorks’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-57,169
Closed -$6.62M 33
2018
Q4
$6.62M Sell
57,169
-5,249
-8% -$586K 4.55% 5
2018
Q3
$6.7M Sell
62,418
-6,092
-9% -$609K 4.24% 8
2018
Q2
$5.84M Sell
68,510
-2,105
-3% -$173K 3.75% 16
2018
Q1
$5.46M Buy
70,615
+863
+1% +$69.5K 4.17% 15
2017
Q4
$5.89M Buy
69,752
+1,627
+2% +$138K 4.38% 10
2017
Q3
$5.83M Buy
68,125
+780
+1% +$64K 4.14% 9
2017
Q2
$5.54M Sell
67,345
-936
-1% -$76.4K 4.15% 11
2017
Q1
$5.74M Sell
68,281
-2,055
-3% -$165K 4.42% 7
2016
Q4
$5.17M Sell
70,336
-162
-0.2% -$12.1K 4.07% 11
2016
Q3
$5.66M Sell
70,498
-2,547
-3% -$204K 5.03% 8
2016
Q2
$5.75M Sell
73,045
-1,097
-1% -$82.6K 4.9% 7
2016
Q1
$5.34M Sell
74,142
-11,846
-14% -$896K 4.57% 11
2015
Q4
$7.25M Sell
85,988
-7,845
-8% -$651K 5.92% 3
2015
Q3
$7.85M Sell
93,833
-47,996
-34% -$4.05M 5.52% 3
2015
Q2
$11.8M Sell
141,829
-4,932
-3% -$376K 6.72% 3
2015
Q1
$10.7M Sell
146,761
-36,069
-20% -$2.57M 5.61% 2
2014
Q4
$12.6M Sell
182,830
-2,097
-1% -$142K 6.21% 1
2014
Q3
$12M Buy
184,927
+595
+0.3% +$37.7K 6.16% 1
2014
Q2
$11.5M Buy
184,332
+176
+0.1% +$10.5K 5.45% 1
2014
Q1
$10.8M Buy
184,156
+1,360
+0.7% +$75.9K 6.38% 1
2013
Q4
$9.32M Buy
182,796
+108,893
+147% +$5.45M 5.07% 5
2013
Q3
$3.72M Buy
73,903
+39
+0.1% +$2.04K 2.29% 21
2013
Q2
$3.63M Buy
+73,864
New +$4.02M 2.11% 24

Other funds holding LLY

ValueWorks's LLY Position: Q1 2019 in Review

ValueWorks sold out of Eli Lilly (LLY) in Q1 2019, closing a stake of 57,169 shares — an estimated $6.62M sold.

ValueWorks first reported a position in LLY in Q2 2013 and held it in 23 quarters. The position peaked at $12.6M in Q4 2014. 1,604 funds tracked by Wall St. Rank hold LLY as of Q1 2019.

  • ValueWorks reported no remaining Eli Lilly position as of Q1 2019 after selling out during the quarter.
  • ValueWorks sold 57,169 Eli Lilly shares in Q1 2019, an estimated $6.62M.
  • ValueWorks first reported a position in Eli Lilly in Q2 2013 and held it in 23 quarters.
  • ValueWorks's Eli Lilly position peaked at $12.6M in Q4 2014.
  • 1,604 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2019.

Based on ValueWorks's 13F filing for Q1 2019, filed 15 May 2019.